PharmaResearch Co., Ltd. (KOSDAQ:214450)
488,500
-5,500 (-1.11%)
Nov 7, 2025, 3:30 PM KST
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 5.08 trillion as of November 7, 2025. Its market cap has increased by 131.44% in one year.
Market Cap
5.08T
Enterprise Value
4.83T
Revenue
449.81B
Ranking
n/a
PE Ratio
39.90
Stock Price
488,500.00
Market Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 5.08T, an increase of 402.88%. That is a compound annual growth rate of 16.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 5.08T | 86.10% |
| Dec 30, 2024 | 2.73T | 144.17% |
| Dec 28, 2023 | 1.12T | 60.18% |
| Dec 29, 2022 | 697.32B | -14.76% |
| Dec 30, 2021 | 818.02B | 48.15% |
| Dec 30, 2020 | 552.15B | 60.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.49T |
| ALTEOGEN | 29.25T |
| SK Biopharmaceuticals | 9.36T |
| Yuhan | 8.57T |
| HLB Co., Ltd. | 6.63T |
| Peptron | 5.88T |
| Hanmi Pharm. | 5.62T |